Literature DB >> 214219

Tubular carcinoma of the breast.

H S Cooper, A S Patchefsky, R A Krall.   

Abstract

Retrospective pathologic review of 636 breast carcinomas from 611 patients revealed twelve tumors which were pure low grade tubular carcinoma (TC) and nineteen tumors with features combining both low grade tubular carcinoma and invasive duct carcinoma (T&D). A control group of 23 cases consisted of invasive duct carcinoma with at least a third of the tumor surface area showing tubular formation, but without the low grade features of tubular carcinoma. Life table analysis at 15 years showed a 100%, 72%, and 33% survival for TC, T&D, and controls, respectively. Eight percent of TC and 21% of T&D had axillary metastases compared to 67% for controls. Axillary metastases had no detrimental effect on TC or T&D survival. There were no recurrences in the TC group. Patients with T&D with tumor diameter 1.0 cm or less with 50% or greater low grade tubular carcinoma component are alive and well. The mean age of T&D was 7 years greater than TC. The combined TC and T&D group showed a significant incidence of multiple cancers in the ipsilateral breast and a significant trend toward bilateral cancers when compared to controls. Tubular carcinoma has an inherently low malignant potential with a histological and biological spectrum.

Entities:  

Mesh:

Year:  1978        PMID: 214219     DOI: 10.1002/1097-0142(197811)42:5<2334::aid-cncr2820420534>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Multicentric Breast Carcinoma: Evaluation of Clinicopathological and Immunohistochemical Characteristics.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Solid Tubular Carcinoma of the Breast: MR Imaging and Pathologic Correlation.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

3.  Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.

Authors:  Audree B Tadros; Hannah Y Wen; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2018-08-09       Impact factor: 5.344

4.  Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.

Authors:  Julie M Jorns; Dafydd G Thomas; Patrick N Healy; Stephanie Daignault; Tammi L Vickery; Jacqueline E Snider; Elaine R Mardis; Sherri R Davies; Matthew J Ellis; Daniel W Visscher
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

5.  c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.

Authors:  J E Somerville; L A Clarke; J D Biggart
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

Review 6.  Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.

Authors:  D J Winchester; A A Sahin; S L Tucker; S E Singletary
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

7.  Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases.

Authors:  G N Peters; M Wolff; C D Haagensen
Journal:  Ann Surg       Date:  1981-02       Impact factor: 12.969

8.  Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

Authors:  E Munzone; A Giobbie-Hurder; B A Gusterson; E Mallon; G Viale; B Thürlimann; B Ejlertsen; G MacGrogan; F Bibeau; G Lelkaitis; K N Price; R D Gelber; A S Coates; A Goldhirsch; M Colleoni
Journal:  Ann Oncol       Date:  2015-09-19       Impact factor: 32.976

9.  Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features.

Authors:  Hee Jung Shin; Hak Hee Kim; Sun Mi Kim; Dae Bong Kim; Ye Ri Lee; Mi-Jung Kim; Gyungyub Gong
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

10.  Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study.

Authors:  C Allemani; M Sant; F Berrino; T Aareleid; G Chaplain; J W Coebergh; M Colonna; P Contiero; A Danzon; M Federico; L Gafà; P Grosclaude; G Hédelin; J Macè-Lesech; C M Garcia; E Paci; N Raverdy; B Tretarre; E M I Williams
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.